Can I read FOLFIRI + Cetuximab in mCRC Study on EtoBox?
FOLFIRI + Cetuximab in mCRC Study by daveliuhk is a document available to read on EtoBox.
What is FOLFIRI + Cetuximab in mCRC Study about?
The ERMES study is a Phase III randomized trial comparing the efficacy and safety of FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in patients with RAS and BRAF wild-type unresectable metastatic colorectal cancer. The primary objective is to assess progression-free survival and toxicity rates, while secondary endpoints include response rates and overall survival. The study aims to determine if a de-escalated treatment approach can maintain disease control while reducing adverse
- Author
- daveliuhk
- Language
- EN